Objective-Ferritin concentrations are often increased in patients with metabolic syndrome and type 2 diabetes mellitus, but few reports have examined the associations between ferritin and atherosclerosis. We investigated whether any relationship between ferritin and coronary artery calcium score (CACS) >0 (as a marker of atherosclerosis) was independent of potential confounders, such as iron-binding capacity (transferrin), low-grade inflammation, and cardiovascular risk factors. Study, plasma iron stores (transferrin saturation ≥55%) were associated with increased all-cause mortality.
B
ody iron stores can be estimated by the measurement of serum ferritin concentration, and increased levels of ferritin (below those observed in hemochromatosis) occur with obesity, metabolic syndrome (MetS), and diabetes mellitus. [1] [2] [3] [4] Iron has a catalytic role in the generation of highly reactive oxygen species, such as hydroxyl radical, through Fenton and Haber-Weiss reactions. 5 The linked iron-induced low-grade inflammatory reaction 6, 7 may contribute, at least in part, to increased risk of atherosclerosis. However, to date, few reports have examined the associations between ferritin and atherosclerosis. In 1992, Salonen et al 8 reported that high stored iron levels were associated with increased risk of myocardial infarction, and in the National Health And Nutrition Examination Survey I Epidemiologic Follow-up Increased tissue iron stores increase risk of diabetes mellitus, and serum ferritin levels have been shown to correlate inversely with insulin sensitivity in the genetic condition hemochromatosis, suggesting that iron metabolism affects peripheral tissue insulin action. 10 Although several lines of evidence suggest that iron may play a role in the pathogenesis of type 2 diabetes mellitus, 11, 12 the mechanism by which increased concentrations of iron cause diabetes mellitus is uncertain. Recently, it has been shown that hepatic iron load is associated with systemic insulin resistance and increased fasting blood glucose levels, and this effect is likely to be a direct effect of iron on metabolism and proinflammatory mechanisms.
Coronary artery calcium scoring (CACS) with cardiac computed tomography is a sensitive method to demonstrate the presence of preclinical atherosclerosis, and the use of CACS may also be useful in identifying individuals at increased risk of cardiovascular disease.
14 Thus, estimation of the CACS provides a useful noninvasive tool to investigate relationships between putative cardiovascular risk factors and preclinical coronary artery atherosclerosis.
Using data from a cohort study with measurements of CACS, together with measurements of overweight, obesity, conventional cardiovascular risk factors, and diabetes mellitus status, we have investigated the relationship between ferritin and a CACS >0. The aim of our study was to test whether any relationship between ferritin (as a marker of tissue iron stores) and a CACS >0 (as a marker of early or preclinical atherosclerosis) was independent of iron-binding capacity (transferrin) and the presence of potential confounders, such as diabetes mellitus, central obesity, MetS features, 15 lowgrade inflammation, individual conventional cardiovascular risk factors, and the Framingham risk score (FRS).
Methods
The study population consisted of individuals who had a comprehensive health check in 2010 at Kangbuk Samsung Hospital, College of Medicine, Sungkyunkwan University in South Korea. Initially, 12 250 male participants underwent coronary computed tomography scanning to establish a CACS, and individuals were excluded from the current analyses if data were missing for the following variables: alcohol consumption (n=68), smoking (n=75), exercise (n=56), body mass index (n=9), waist circumference (n=9), and high-sensitivity C-reactive protein (hs-CRP) (n=134). Data from 12 033 participants were analyzed. In South Korea, employees are required to participate in annual or biennial health checks by the Industrial Safety and Health Law. Some subjects voluntarily pay for these health checks and in other instances the individual's employer pays for the health check. Health checks include blood tests, anthropometry, and abdominal ultrasound examination, and in some cases, the health check can include calcium scoring computed tomography. The CACS test is offered as part of the health check program, and, therefore, there is no medical indication for performing the test. Consequently, there are no specific inclusion or exclusion criteria because since this is a health check, the participants were not required to give consent for research. The Institutional Review Board at Kangbuk Samsung Hospital has ruled that because our study is an analysis of routine data and we are not accessing personal identifiable information, there is no need to obtain specific informed personal consent.
The health check included collection of full medical history, physical examination, and blood sample. Body mass index was calculated as weight in kg divided by height in m 2 . Questionnaires were used to ascertain information regarding alcohol consumption (glasses/day), smoking (never, ex, current), and frequency of moderate activity each week. Moderate activity was defined as >30 minutes of activity per day that induced slight breathlessness.
Blood samples for laboratory tests were collected after an overnight fast. Fasting plasma glucose, total cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol concentrations were measured using Bayer Reagent Packs on an automated chemistry analyzer (Advia 1650 Autoanalyzer; Bayer Diagnostics, Leverkusen, Germany). Concentrations of serum ferritin were measured by an electrochemiluminescence immunoassay using the Modular E170 analyzer (Roche Diagnostics, Indianapolis, IN). The total coefficients of variation for serum ferritin determinations were ≤4.3% and ≤4.9% for normal range control and high-level quality control samples during the study period, respectively. Hs-CRP was analyzed by particleenhanced immunonephelometry with the BNII System (Dade Behring, Marburg, Germany) using a lower detection limit of 0.175 mg/L.
Computed tomography scans were performed with a 64-slice MDCT scanner (Lightspeed VCT XTe-64 slice; GE Healthcare, Milwaukee, WI), and a standard scanning protocol was 32×0.625-mm section collimation, 400-ms rotation time, 120-kV tube voltage, and 31 mAS (310 mA×0.1 second) tube current under ECG-gated dose modulation. The quantitative CACS were calculated according to the method described by Agatston et al. 16 The presence of preclinical CAC was defined by CACS >0.
Statistical Analysis
Statistical analysis of the data was performed using SPSS version 15.0 (SPSS, Point Richmond, CA). Continuous variables were expressed as mean±SD for normally distributed variables or median (interquartile range) if not normally distributed. Categorical variables were expressed as percentages and compared between groups using the χ 2 test. We used logistic regression analysis to determine the odds ratio (OR) of presence of coronary calcium associated with increasing quartiles of ferritin concentration (quartile 1=reference). The following variables were entered into logistic regression to investigate the independence of the relationship between ferritin quartile and CACS >0: age, sex, smoking status (never, ex, current), frequency of moderate activity a week (defined by ≥1 episode of moderate activity of >30 min/day that induced slight breathlessness), low-density lipoprotein cholesterol concentration, alcohol consumption (g/day), transferrin, history of cerebrovascular accident, coronary heart disease, hypertension and diabetes mellitus diagnosed by questionnaire, hs-CRP, FRS, and features of the MetS. 15 FRS quartiles were established. P<0.05 was considered to be statistically significant. Table 1 compares the baseline characteristics of people with a CACS >0 with those who had a CACS=0, and 1351 of 12 033 subjects (11.2%) had a CACS >0. Conventional cardiovascular risk factors were adversely affected in subjects with a CACS >0 compared with subjects with a CACS=0, and 12.0% of subjects with a CACS >0 had diabetes mellitus compared with 3% of subjects having diabetes mellitus with a CACS=0 (P<0.001). Median interquartile range serum ferritin concentration was 196.8 (136.3-291.9) ng/mL in people with a CACS >0 compared with 182.2 (128.1-253.6) ng/mL in people with a CACS=0 (P<0.001).
Results
We investigated the relationships between ferritin concentrations and CACS >0 (Table 2 ). In the highest ferritin quartile, 14.7% of subjects (442/3008) had a CACS>0 compared with 9.7% of subjects (292/3010) in the lowest quartile. Increasing ferritin quartiles led to a higher proportion of people with hypertension, coronary heart disease, and a 10-year FRS ≥10%. Regardless of whether the 10-year FRS was <10% or ≥10%, there was a higher proportion of people in the highest ferritin quartile who had a CACS >0 (FRS <10%, P<0.0001; FRS ≥10%, P=0.007).
We investigated the relationship between increasing ferritin quartiles and CACS >0, controlling for multiple other traditional cardiovascular risk factors, transferrin, alcohol, and features of the MetS, to study whether there was an inde pendent relationship between ferritin quartile and CACS >0 (Table 3) . Increasing ferritin quartile was associated with a CACS >0, independently of all other factors entered into the model (Table 3) . For people in the highest quartile of ferritin concentration, the OR for the presence of CACS >0 was 1.66 (95% CI, 1.39-1.98; P=0.0001). There was a borderline significant relationship between FRS ≥10% and CACS >0 (OR, 1.15 [95% CI, 0.99-1.35]; P=0.07) after adjustment for all other factors in the model. We repeated the multivariable logistic regression model shown in Table 3 , investigating associations between multiple cardiometabolic risk factors, ferritin as a continuous variable, and CACS >0. There was also a significant association between ferritin and CACS >0 (OR, 1.001 [95% CI, 1.001-1.002]; P<0.0001) for each ng/mL increase in ferritin.
Two-thousand five-hundred-fifty-two women also underwent CACS as part of the health check. Of these women, only 111 had a CACS >0. Increasing ferritin quartiles led to a linear increase in the percentage of women with a CACS >0 in each quartile, P<0.0001 for the linear trend across quartiles. In the highest ferritin quartile, 10.5% of women had a CACS >0 compared with 1.4% in the first ferritin quartile. There were 2.0% and 3.4% of women with a CACS >0 in the second and third ferritin quartiles.
When analyzing the data for women alone, we repeated the multivariable logistic regression model shown in Table 3 We repeated the multivariable logistic regression model shown in Table 3 for men and women combined, investigating associations among multiple cardiometabolic risk factors, ferritin as a continuous variable, and CACS >0. There was also a significant association between ferritin and CACS >0 (OR, 1.001 [95% CI, 1.001-1.002]; P<0.0001) for each ng/mL increase in ferritin.
We estimated the OR for CACS >0 in people in the highest ferritin quartile (versus the other 3 quartiles as reference) according to increasing FRS quartiles (Table 4 ). ORs were adjusted for age (model 1) and other cardiovascular risk factors (Table 4 , models 2-4). ORs were remarkably similar across FRS quartiles, regardless of the level of adjustment.
Discussion
Our novel results show that, in this relatively young occupational cohort, 11.2% of subjects had a CACS >0, a marker of early atherosclerosis, and ferritin concentrations were independently associated with a CACS >0 after adjustment for iron-binding capacity (transferrin), traditional cardiovascular risk factors, MetS factors, and a measure of low-grade inflammation (hs-CRP). For people in the highest ferritin quartile (compared with the lowest quartile), the OR for the presence of CACS >0 was 1.66 (95% CI, 1.39-1.98). With increasing ferritin quartiles, there was also a higher proportion of people with diabetes mellitus, hypertension, coronary heart disease, and a 10-year FRS ≥10%. Only 2552 of 14 585 (17.5%) subjects in this occupational cohort were women, and the proportion of women with a CACS >0 was only 111 of 2552 (4.3%). Consequently, the number of women with a CACS >0 is too small for us to comment on whether ferritin is also independently associated with coronary atherosclerosis in women.
Ferritin is an acute-phase protein, and its expression is upregulated in conditions such as uncontrolled cellular proliferation, in any condition marked by excessive production of toxic oxygen radicals, and by infectious and inflammatory processes. Under such conditions, ferritin upregulation is predominantly stimulated by increased reactive oxygen radical production and cytokines. 17 Consequently, there is still uncertainty as to whether any relationship between ferritin and cardiometabolic diseases reflects a relationship with a recognized marker of iron status or is an epiphenomenon, with increased ferritin concentrations reflecting metabolic stress. In contrast to many other studies, we have attempted to address this issue by studying the relationships between CAC and transferrin (as a marker of plasma iron-binding capacity), and CAC and ferritin (as a marker of tissue iron stores and metabolic stress). Our data suggest a stronger independent association between ferritin than transferrin, and CACS >0, and importantly the relationship between ferritin and CACS >0 was independent of transferrin, as a marker of plasma iron-binding capacity. Thus, we can speculate that some other unmeasured Data are mean±SD or median (interquartile range) unless otherwise noted. CAC indicates coronary artery calcium; cholesterol, total cholesterol; LDLc, low-density lipoprotein cholesterol; HDLc, high-density lipoprotein cholesterol; BMI, body mass index; Hx, prior history; CVA, cerebrovascular accident; CHD, coronary heart disease; HTN, hypertension, defined by systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or medication for HTN; HR, heart rate; Hs-CRP, high-sensitivity C-reactive protein.
*Ferritin (median and IQR). Physical activity category defined by ≥1 episode of moderate activity of >30 min/d that induced slight breathlessness.
factor (eg, metabolic stress), in addition to iron metabolism, may influence the relationship between ferritin and CACS >0 score.
Our novel findings, showing an independent association between ferritin concentrations and CACS >0 as a marker of preclinical atherosclerosis in an Asian cohort, are similar to those reported in a white northern European cohort from Eastern Finland. 8 In the Finnish cohort of 1931 men aged 42, 48, 54, and 60 years who were free of symptomatic coronary heart disease at entry, high stored iron levels were a strong risk factor for myocardial infarction during an average follow-up of 3 years. Importantly, this effect was present in all multivariable regression models, even after adjustment for multiple relevant potential confounders that included age, smoking, ischemic ECG on exercise testing, maximal oxygen uptake, systolic blood pressure, blood glucose, serum copper, blood leukocyte count, high-density lipoprotein cholesterol, apolipoprotein-B, and triglyceride concentrations. In support of the evidence 8 and our presented data (suggesting that increased ferritin concentration is an independent risk factor for early or preclinical atherosclerosis), the National Health And Nutrition Examination Survey I Epidemiologic Follow-up Study investigators studied the relationships among transferrin saturation and dietary iron intake and all-cause mortality. 9 In this study of 9229 people aged 35 to 70 years at baseline, there was a hazard ratio for death of 2.90 (95% CI, 1.39-6.04) in subjects with a high transferrin saturation (>55%) and a high dietary iron intake (>18 mg/day) compared with those who had a normal transferrin saturation and a low or normal dietary iron intake. Because the National Health And Nutrition Examination Survey II surveys included a caution about conducting statistical analyses using ferritin results (due to the small population size in which this analyte was measured), the investigators did not test associations with ferritin and all-cause mortality in their cohort.
Other studies have also noted associations between markers of iron status and vascular disease, 18 but these data have not been consistent and some studies have failed to show any association between markers of iron homeostasis and vascular disease. 19, 20 It is noteworthy that most of the epidemiological CACS indicates coronary artery calcium score; FRS, Framingham Risk Score; physical activity category (moderate activity defined as >30 min activity per day that induced slight breathlessness ≥1/wk); SBP, systolic blood pressure; LDLc, low-density lipoprotein cholesterol; HDLc, high-density lipoprotein cholesterol; Hx, prior history; CVA, cerebrovascular accident; CHD, coronary heart disease; HTN, hypertension, defined by SBP ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or medication for HTN; HR, heart rate; Hs-CRP, high-sensitivity C-reactive protein. studies that have examined relationships between markers of iron status and cardiovascular disease have focused on cardiovascular events using end points such as myocardial infarction. Myocardial infarction occurs as a consequence of a heterogeneous disease process involving atherothrombosis and plaque rupture. Consequently, many different factors besides atheroma formation are important in the pathogenesis of ischemic heart disease. Because our intention was to study the relationship between a marker of tissue iron status (ferritin) and preclinical atherosclerosis, we have examined the relationships between ferritin and a marker of preclinical atherosclerosis (CACS). Recently, others have shown in much smaller cohorts than ours that increased ferritin concentration was independently associated with preclinical measures of vascular disease. In a cohort of people with nonalcoholic fatty liver disease, it has been shown that carotid intima medial thickness and carotid plaque were associated with increased ferritin concentration independently of liver fat. 21 It has also been shown that there was an independent association between serum ferritin concentrations and arterial stiffness (pulse wave velocity) even after adjusting for age and sex. 22 There is now evidence that iron accumulates in atherosclerotic plaques in contrast to healthy blood vessels. 23 Since 2000, it has been acknowledged that hepcidin is a key regulator of iron homeostasis, and hepcidin may mediate the increase in ferritin concentrations in inflammatory states. 24, 25 Thus, hepcidin may promote the retention of iron bound to ferritin within macrophages in atherosclerotic plaques. In support of the potential importance for the accumulation of iron within macrophages in atherosclerotic plaques, heme oxygenase 1 promoter polymorphisms are associated with increased serum ferritin concentrations 26 and increased risk of cardiovascular disease. 27 (N.B. Heme oxygenase 1 is an important enzyme that facilitates mobilization of iron from tissue macrophages.) In addition, evidence from animal studies also supports the notion that decreasing tissue iron is beneficial for decreasing risk of atherosclerotic vascular disease. It has been shown that removal of tissue iron by chelating therapy, dietary iron restriction, or phlebotomy decreases atheroma plaque size, and this change improves plaque stability. [28] [29] [30] [31] Consequently, this body of evidence suggests a potential novel mechanism for decreasing atherosclerotic plaque formation in humans by decreasing plaque iron content. That we have observed a stronger relationship between ferritin and CACS >0, than between transferrin and CACS >0, also adds further weight to the concept that it is tissue iron accumulation rather than the relative saturation of plasma iron-binding protein that is important in atherosclerosis.
Whereas FRS is useful for estimating the 10-year risk of cardiovascular events, addition of the CACS improves risk prediction in Western populations beyond the use of FRS alone. 32, 33 Several lines of evidence indicate that inflammation plays a pivotal role in atherosclerosis, and increases in hs-CRP (as a marker of inflammation) occur with atherosclerotic vascular disease. 34 However, to date, the relationship between hs-CRP and the burden of coronary atherosclerosis is not clear, and our data show that hs-CRP was not independently associated with CACS >0 (Table 3 ). The absence of n independent association between hs-CRP and CACS >0 is not clear, but one possibility is that inflammation is more strongly related to plaque rupture and thrombosis than to the presence of atherosclerosis. Better markers of vascular inflammation are required, and given the evidence discussed above (that ferritin is increased in inflammatory states) and because ferritin was associated with hs-CRP in our cohort (r=0.17; P<0.001 in univariate analysis), we suggest that further work is required to investigate the role of ferritin, not only as a marker of tissue iron stores but also as a possible marker of vascular inflammation in preclinical atherosclerosis.
There are limitations to our study. The sample size for women is small, although the relationships between ferritin and CACS >0 were similar in women. Our study shows associations between ferritin and CACS >0, and this study design cannot test causal relationships. In addition, our study is limited to one ethnic group, and the distribution of risk factors and the association between ferritin and CAC may differ by ethnic group.
In conclusion, we have shown that ferritin concentrations are associated with the presence of CAC (as a marker of preclinical atherosclerosis), independent of diabetes mellitus, MetS features, other conventional cardiovascular risk factors, and preexisting cardiovascular disease. Further research is required to investigate whether ferritin improves prediction of cardiovascular risk. Reference: ferritin <75th centile. Ten-year FRS quartile thresholds: quartile 1 ≤2%; quartile 2 >2 to ≤5%; quartile 3 >5 to ≤10%; and quartile 4 >10%. OR indicates odds ratio; CACS, coronary artery calcium score; FRS, Framingham Risk Score; HTN, hypertension, defined by systolic blood pressure ≥140 or diastolic blood pressure ≥90 or medication for HTN; CVA, cerebrovascular accident; CHD, coronary heart disease; DM, diabetes mellitus; LDLc, low density lipoprotein cholesterol; TG, triglyceride; HDLc, high-density lipoprotein cholesterol; LDLc, LDL cholesterol; hs-CRP, high-sensitivity C-reactive protein.
*ORs were estimated for highest ferritin quartile vs other 3 quartiles.
